Drop off your CV/Resume
We'd love to hear from you. Send us your CV/Resume and one of our team will be in touch.
Supporting Growth Across Small Molecule, Biologics and Cell & Gene Therapy
The CDMO industry is growing fast, with forecasts putting it on track to surpass $315 billion by 2030. As pharma and biotech companies continue to outsource development and manufacturing, the pressure is on to deliver faster, more cost-effective, and more flexible solutions. North America and Europe remain central to this shift, the US leading the way in biologics and cell & gene therapy, while countries like Germany, Switzerland, and the UK double down on GMP manufacturing capabilities.
We work closely with CDMOs across small molecule, biologics, and advanced therapy platforms. As demand rises and timelines tighten, these organisations need access to highly skilled technical professionals, not just to fill roles, but to keep pace with regulatory change, operational complexity, and global scale-up efforts.
Across both the US and Europe, we’re seeing major investment in new sites, cutting-edge technology, and expanded capacity. But at the heart of it all is one thing: people. No matter how advanced the equipment or how ambitious the growth plans, it’s the teams behind the work that determine success. The right talent brings more than technical execution, it fuels innovation, maintains compliance, and keeps operations running efficiently at scale.
Some of the most in-demand roles across the CDMO space right now include Process Development Scientists who can fine-tune yields and ensure smooth tech transfer between sites, and MSAT specialists who sit at the intersection of R&D and manufacturing, making sure what works in the lab can be scaled compliantly on the floor.
There’s also growing demand for QA/QC and Regulatory Affairs professionals who know their way around global frameworks and can confidently guide programs through inspections and audits. And on the operational side, Manufacturing Engineers and Plant Leaders with hands-on GMP experience and a systems-thinking approach are playing a huge role in helping CDMOs scale up without compromising on quality.
Attracting and keeping hold of this level of specialist talent is quickly becoming a competitive advantage in itself. It’s what allows CDMOs to stay audit-ready, meet the expectations of their partners, and continue growing in a fast-moving, highly regulated market.
Let us support you in taking the next step in your life sciences career. Talk to our team today to find your next position, or simply explore your options while browsing our latest opportunities.